Salas-Whalen, author of the book, Weightless: A Doctors Guide to GLP-1 Medications, Sustainable Weight Loss, and the Health You Deserve ," cited estimates that half of the world population will have obesity by 2030, which has implications on everything from rates of type 2 diabetes to certain cancers
Drug interactions Berberine may inhibit several cytochrome P450 enzymes (including CYP3A4, CYP2D6, and CYP2C9) and P-glycoprotein, potentially affecting the metabolism of numerous medications including statins, anticoagulants, antihypertensives, and immunosuppressants
*Correspondence: Mitja Krajnc, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
In GSE appears to protect against oxidative stress and A Keep in mind that the anticancer and chemopreventive potential of GSE and its proanthocyanidins may not be directly transferable to people with cancer